Delta Biosensing
Biotechnology - , ,
Delta Biosensing Employees
Delta Biosensing Details
Delta Biosensing is developing a novel and patent pending platform technology to confirm the presence of living bacteria in a rapid, accurate, and inexpensive manner. The overall market for this kind of test is broad and includes identifying targeted bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and other antibiotic resistant organisms (AROs) in hospital, nursing home, and school environments; Mycobacterium tuberculosis , especially multidrug-resistant strains (MDR-TB), in human populations; Escherichia coli O157:H7, Listeria monocytogenes, and Salmonella in produce handling and food processing facilities; and various homeland security applications. The first targeted market is hospital-acquired MRSA (HA-MRSA) where the demand for a faster, cheaper, and simpler test is high and the cost for not having such a test is prohibitive. Immediate follow-on applications are point-of-care tuberculosis and food safety testing.
